James M. Markert

University of Alabama at Birmingham — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

55h-index12.3kcitations370works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(158), CAR-T cell therapy research(106), Glioma Diagnosis and Treatment(89), Herpesvirus Infections and Treatments(78), Brain Metastases and Treatment(44)

Publications368 total

A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessment
The Lancet Oncology·2025· 1 cited
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 1: intraoperative recommendations for mapping, monitoring, and decision making
The Lancet Oncology·2025· 1 cited
Quantitative dynamic granzyme B PET imaging to characterize novel combination immunotherapy response in preclinical glioblastoma models
Theranostics·2025Open Access
Figure S1 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
2025Open Access
Figure S4 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
2025Open Access
Figure S2 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
2025Open Access
Figure S7 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
2025Open Access
Figure S6 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
2025Open Access
Figure S3 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
2025Open Access
Figure S8 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
2025Open Access
Figure S5 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
2025Open Access
IMMU-83. CD4 T-cell reprogramming via oncolytic virotherapy enhances survival in glioblastoma
Neuro-Oncology·2025Open Access
TMIC-119. Evaluating the Impact of Tumor-Secreted Fibronectin-1 on the Perivascular Niche (PVN) and Glioblastoma Malignancy
Neuro-Oncology·2025Open Access
EXTH-113. Radiation synergizes with IL-12-expressing oncolytic herpes simplex virus to increase immune response in a murine model of high-grade glioma
Neuro-Oncology·2025Open Access
IMG-133. System L amino acid ([F-18]FET) and hypoxia ([F-18]FMISO) PET/MRI to assess early response after completion of radiation therapy in high grade glioma
Neuro-Oncology·2025Open Access
Survival outcomes associated with antidepressant use in glioblastoma: a cohort study
Journal of Neuro-Oncology·2025Open Access
Comparison of 3 vs 5 Fraction Single Isocenter Radiosurgery for Brain Metastases
Advances in Radiation Oncology·2025Open Access
Frameless linac-based radiosurgery for benign intracranial tumors treated with HyperArc: analysis of tumor control and toxicity
Journal of Neuro-Oncology·2025Open Access
Challenges and Opportunities in High-Grade Glioma Management and Imaging-Based Response Monitoring During Novel Immunotherapies
Cancers·2025· 2 citedOpen Access
HyperArc Automated Stereotactic Radiosurgery Planning Enables Accurate a Priori Fractionation Scheme Selection via Adherence to HyTEC Toxicity Thresholds
Advances in Radiation Oncology·2025Open Access
page 1 of 19Next →

Frequent Co-authors

G. Yancey Gillespie(26), John B. Fiveash(11), Richard J. Whitley(10), Jacqueline N. Parker(8), Burt Nabors(7), Cheryl A. Palmer(6), Gregory K. Friedman(6), Barton L. Guthrie(6), Joshua D. Bernstock(5), Bernard Roizman(5), Kevin A. Cassady(5), Jennifer Coleman(4), Dale Benos(4), Kristen Riley(4), Catherine P. Langford(4), Alfred D. Lakeman(3), Ralph R. Weichselbaum(3), Li Nan(3), Catherine M. Fuller(3), James K. Bubien(3)